Cancer phospholipidome

In general, the present invention relates to identification of lipidome biomarkers for cancer analysis and it provides prognostic and predictive methods and kits for cancer diagnosis and subtyping and for diagnosing and/or predicting the evolution of a tumor and its response to lipid metabolism-targeted or other types of therapy in a subject, by making use of phospholipid (PL) profiling, wherein changes in the combined acyl chain length of intact body fluid-derived or tumor-derived phospholipid species is indicative of an elongation phenotype.

Patent Publication Number: US9400274

Year filing: 2013

Year approval: 2016

Year publication: 2016

Status: Assigned

Technology domains: Analysis of biological materials

Validated for IOF-key: Yes

Attributed to: Associatie KULeuven